Skip to main content Skip to navigation
Make an Appointment Today 1-888-884-BEAR (2327) 1-888-884-BEAR (2327)
Find a Doctor Donate
Call Us Menu
We care about your privacy. Read about your rights and how we protect your data. Get Details

Innovative Phase 1 Trial to Protect the Brains of Infants with Critical Congenital Heart Disease During and After Surgery (MEDCAP)

Share:
Linked In Print Email

A phase 1 trial at Children's National Hospital studies the use of mesenchymal stromal cells (MSCs) as a potential protection for the brains of infants undergoing cardiac surgery. This is the first study to infuse these MSCs via the cardiopulmonary bypass, or heart-lung machine.

About the Expert

Mary Donofrio

Mary Donofrio, MD, FACC, FASE Medical Director, Prenatal Cardiology Program
Co-Director, Cardiac Neurodevelopmental Outcome Program
Advanced Imaging Cardiologist

Catherine Bollard

Catherine Bollard, M.D., M.B.Ch.B. Director, Center for Cancer & Immunology Research
Bosworth Chair for Cancer Biology
Director, Program for Cell Enhancement and Technologies for Immunotherapy (CETI)
Attending Physician, Division of Bone and Marrow Transplantation

Richard Jonas

Richard Jonas, M.D. Emeritus Chief, Division of Cardiac Surgery
Senior Investigator, Center for Neuroscience Research

Nobuyuki Ishibashi

Nobuyuki Ishibashi, M.D. Foglia-Hills Professor of Pediatric Cardiac Research
Director of Cardiac Surgery Research Laboratory
Principal Investigator

Invest in future cures for some of life's most devastating diseases

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Make it happen